Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBMX pseudogene 5 is an intronless, nonfunctional copy (pseudogene) of the RBMX gene, identified as NCBI Gene ID 100288788[3][4]. RBMX is a protein-coding gene encoding a ubiquitous RNA-binding protein involved in RNA splicing and gene regulation, but RBMXP5 itself contains disabling mutations and does not encode a functional protein[4][5]. Pseudogenes like RBMXP5 may exert minor regulatory effects at the RNA level, such as acting as decoys for microRNAs or RNA-binding proteins, but there is no evidence RBMXP5 has such a role[2][4]. It is not a known drug target, does not encode a receptor, enzyme, or transporter, and is not implicated in any human diseases. It is catalogued purely as a pseudogene[3][4]. RBMXP5 is one of several pseudogenes derived from the RBMX (RNA binding motif protein X-linked) gene family by retrotransposition events during vertebrate evolution. Unlike its parent gene RBMX—which has roles in mRNA processing, tumor suppression, and neuronal development—RBMXP5 is noncoding and regarded as nonfunctional[4]. Some pseudogenes in other contexts are documented to influence gene expression via RNA-based regulatory mechanisms, but there is no specific evidence for any such role for RBMXP5 itself[2][4]. RBMX pseudogene 5 (RBMXP5) is a nonfunctional genomic element, not a drug target, not involved in diseases, and has no known biological, clinical, or pharmacological function[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBMX pseudogene 5 (RBMXP5).